Severe Hepatic Sinusoidal Obstruction Syndrome in a Child Receiving Vincristine, Actinomycin-D, and Cyclophosphamide for Rhabdomyosarcoma: Successful Treatment with Defibrotide

Aery CHOI; Young-Kyung KANG; Sewon LIM; Dong-Ho KIM; Jung-Sub LIM; Jun-Ah LEE.
Cancer Research and Treatment ; : 1443-1447, 2016.
Artículo en Inglés | WPRIM | ID: wpr-205891

Documentos relacionados

  1. Caso clínico: Enfermedad Veno-Oclusiva Hepática secundaria a Quimioterapia en un paciente con Sarcoma de Ewing
  2. Severe Hepatic Sinusoidal Obstruction Syndrome in a Child Receiving Vincristine, Actinomycin-D, and Cyclophosphamide for Rhabdomyosarcoma: Successful Treatment with Defibrotide.
  3. Veno-occlusive disease in a child with rhabdomyosarcoma after conventional chemotherapy: report of a case and review of the literature.
  4. Transjugular Intrahepatic Portosystemic Shunt for Very Severe Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) after Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation with Post-transplantation Cyclophosphamide.
  5. [Diagnosis and treatment of sinusoidal obstruction syndrome (veno-occlusive disease)].
  6. Imaging features of hepatic sinusoidal obstruction syndrome or veno-occlusive disease in children.
  7. Anatomic and Clinical Pathology Characterization of Drug-Induced Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease) in Cynomolgus Macaques.
  8. Autotaxin is a potential predictive marker for the development of veno-occlusive disease/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation.
  9. Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group.
  10. Hepatic Sinusoidal Obstruction Syndrome in a child after chemotherapy for medulloblastoma.